A Significant Accomplishment for the PLSG and the Life Sciences Industry in
PITTSBURGH, April 30 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, announced that the PLSG has reached a significant milestone with over $10 million in direct company investments. PLSG's investment of $235,000 in Lipella Pharmaceuticals for the support of pre-clinical testing and manufacturing of their therapy for the treatment of bladder dysfunction pushed them over the $10 million mark.
Since forming in 2002, the PLSG has committed $10.1 million into its Investment Portfolio of 48 life sciences companies which has leveraged over $300 million in additional capital for these emerging businesses. The PLSG continues to propel the growth of western Pennsylvania's life sciences economy by investing in the commercialization of promising life sciences technologies.
"Hitting the $10 million mark is a significant accomplishment for the PLSG and the life sciences industry in our region," said John W. Manzetti, PLSG president & CEO. "We are making a significant impact on life sciences commercialization in western Pennsylvania: new company formation is up, new wealth is being created, and new products -- with important, positive ramifications for human health and quality of life -- are beginning to reach the marketplace."
As western Pennsylvania's only organization solely focused on the biosciences industry, the PLSG has brought the required energy, domain-specific expertise and efficiency to the task of establishing a critical mass of life sciences awareness, research, development and commercialization in the region. The task moving forward is to expand those efforts and increase the successful commercialization of viable life sciences ventures.
|SOURCE The Pittsburgh Life Sciences Greenhouse|
Copyright©2008 PR Newswire.
All rights reserved